A tale of two sentiments two weeks after FDA permits the sale of IQOS

By Darlene Huang | Leave a Comment

It’s been just over two weeks since the U.S. Food and Drug Administration (FDA) authorized the sale of Philip Morris’ IQOS heated tobacco product (HTP) system in regular tobacco and menthol flavors. It’s also been exactly two years since the premarket tobacco product application (PMTA) for this product that creates an aerosol (not smoke) from […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: continuum of risk, heated tobacco, tobacco control.

04.04.19

Reflecting on progress made in tobacco and nicotine products regulation under FDA Commissioner Gottlieb

By Darlene Huang | Leave a Comment

Tomorrow is Commissioner Gottlieb’s last day on the job at the U.S. Food and Drug Administration (FDA), and he’s been treating these last few days much like he has his entire two-year tenure: with carefully thought out and coordinated communication about both in-process and potential future FDA actions. While the agency has been hard at […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: e-cigarettes, medical products, nicotine, tobacco control.

02.11.19

Reality check: Cigarettes are the only reason reduced risk tobacco products are even a thing

By Darlene Huang | Leave a Comment

First, a confession. I’m a total public health nerd. I’ve been absolutely captivated by the prevention of disease at a population level since I was introduced to the concept late in college. From the science that drives it to the programs, policies, and laws that either embrace or hinder it and everything in between and […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: Harm Reduction, misperceptions, modified risk tobacco products, smokeless tobacco, tobacco control.

01.25.19

Develop your skills blending law, science, and policy as a Tobacco Regulatory Science Fellow at the U.S. Food and Drug Administration

By Darlene Huang | Leave a Comment

At my high school graduation, a friend and I had a short dialogue speaking to our graduating class about where our futures were headed. “What do you want to be when you grow up?” I asked her. She confidently answered, “A horse.” After an awkward moment or two went by, she continued with, “Or at […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: nicotine, regulatory science, tobacco control.

12.11.18

Furthering Tobacco Control Requires a Broader Perspective

By Darlene Huang | Leave a Comment

Tobacco control efforts in the U.S. have predominantly been a state, local, and increasingly tribal endeavor with landmark federal reports and legislation spurring or guiding local actions. When I started in tobacco control at the local level in 2006, the CDC’s Best Practices for Comprehensive Tobacco Control Programs was our roadmap. It focused our efforts […]

Posted in FDA, Food and Drug Law, Non-Communicable Diseases, Tobacco ; Tagged: drugs, medical devices, medical products, nicotine, Pharmaceuticals, tobacco control.

08.10.18

Preventive Care and The Health Coach Revolution

By Mehgan Gallagher | Leave a Comment

There has been a recent surge of talk about health coaches popping up in gyms, doctors’ offices, and in magazines. A health coach is someone who is educated in the field of exercise, nutrition, diet, and overall well-being. The Institute for Integrative Nutritiondefines a health coach as “a wellness authority and supportive mentor who motivates […]

Posted in Health reform, Non-Communicable Diseases, Resources ; Tagged: Diet, health, NCDs, nutrition, obesity, public health.

07.27.18

Progress Towards Addressing Health Challenges and Inequity in Namibia

By Drew Aiken | Leave a Comment

Last week, the Namibian Ministry of Health and Social Services launched the 2018-2022 National Strategic Plan and held the inaugural National Health Assembly. The National Health Assembly is a forum to discuss health issues and challenges in the country, including the development of the UHC framework which is presently underway. National Health Assemblies have […]

Posted in Global Health, Health and Human Rights, Human Rights, Infectious Diseases, Non-Communicable Diseases, TB ; Tagged: global health equity, namibia.

05.01.18

Utilizing Usable Technology to Improve Health Outcomes

By Mehgan Gallagher | Leave a Comment

I recently experienced one of the biggest scares of my life when my dad wound up in the emergency room for his failing heart. My dad, who is 59 years old, suffered a heart attack seven years ago around this time of year. In an eerie coincidence, the day he had his heart attack, […]

Posted in Non-Communicable Diseases ; Tagged: NCDs, non-communicable diseases, public health.

01.25.18

GULF COUNTRIES IMPOSE NEW TAXES ON TOBACCO AND SUGARY DRINKS, DOUBLING PRICES TO A HISTORICAL HIGH

By Han-Hsi Indy Liu | Leave a Comment

Hanhsi Indy Liu and Hisham Ali Alsabt are SJD candidates at Georgetown University Law Center. Any questions or comments on this post can be sent to: hl580@georgetown.edu or ha374@georgetown.edu. Arabian Gulf countries, known for their high oil revenues and low tax rates for decades, have recently been suffering from declining oil revenues. To reduce their reliance […]

Posted in Non-Communicable Diseases, Tobacco, Trade ; Tagged: NCDs, obesity, public health law, soda tax, tobacco control.

10.27.17

SAN FRANCISCO SODA WARNING RULE CHILLS PUBLIC HEALTH EFFORTS

By O’Neill Institute | Leave a Comment

Hanhsi Indy Liu is an SJD candidate at Georgetown University Law Center. Sarah Roache is the director of Global Health Law LL.M. Program and Capacity Building Initiative at the O’Neill Institute for National and Global Health Law. Any questions or comments on this post can be sent to: hl580@georgetown.edu. Supporters of regulations to reduce consumption of […]

Posted in Non-Communicable Diseases ;

Recent Posts
Recent Comments
Categories
Archives
Archives
3417976 items 1 default desc

O’Neill Institute, Harrison Institute for Public Law, and Health Justice Alliance. “Oral Health Convening Focusing on Children with Special Health Care Needs,” March 29, 2018. http://oneill.law.georgetown.edu/media/ONL_Oral_Health_Report_P3_web.pdf.

Kavanagh, Matthew. “Good Health Supports Good Governance.” Foreign Policy, May 25, 2019. https://foreignpolicy.com/2019/05/24/good-health-supports-good-governance/.

Gostin, Lawrence, Ibrahim Abubakar, Ranieri Guerra, Sabina F Rasid, Eric Friedman, and Zsuzanna Jakab. “WHO Takes Action to Promote the Health of Refugees and Migrants.” The Lancet 393, no. 10185 (May 18, 2019). https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(19)31051-7/fulltext.

Gostin, Lawrence. “The ‘Conscience’ Rule: How Will It Affect Patients’ Access to Health Services?” News@JAMA, May 15, 2019. https://newsatjama.jama.com/2019/05/15/jama-forum-the-conscience-rule-how-will-it-affect-patients-access-to-health-services/.

Friedman, Eric A. “How to Achieve Health Equity.” Project Syndicate, March 6, 2019. https://www.project-syndicate.org/commentary/health-equity-sdgs-programs-of-action-by-eric-a-friedman-2019-03.

Kavanagh, Matthew, and Lixue Chen. “Governance and Health Aid from the Global Fund: Effects Beyond Fighting Disease.” Annals of Global Health 85, no. 1 (May 12, 2019): 69. http://doi.org/10.5334/aogh.2505.

Gostin, Lawrence O., John T. Monahan, Jenny Kaldor, Mary DeBartolo, Eric A Friedman, Susan C Kim, Ala Alwan, et al. “The Legal Determinants of Health: Harnessing the Power of Law for Global Health and Sustainable Development.” The Lancet, April 30, 2019. https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(19)30233-8.pdf#%20.

Friedman, Eric A. “How to Achieve Health Equity.” Project Syndicate, March 6, 2019. https://www.project-syndicate.org/commentary/health-equity-sdgs-programs-of-action-by-eric-a-friedman-2019-03.

Gostin, Lawrence O. “A National Action Plan to Eliminate Vaccine Preventable Childhood Diseases.” The Milbank Quarterly, May 6, 2019. https://www.milbank.org/quarterly/articles/a-national-action-plan-to-eliminate-vaccine-preventable-childhood-diseases/?utm_content=buffer64e0e&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer.

Lindblom, Eric. “If E-Cigarettes Are a Top Priority, Why Hasn’t the FDA Issued a New Rule?” The Washington Post, March 24, 2019. https://www.washingtonpost.com/opinions/if-e-cigarettes-are-a-top-priority-why-hasnt-the-fda-issued-a-new-rule/2019/03/24/a5efdb58-4cc2-11e9-8cfc-2c5d0999c21e_story.html?utm_term=.0bec677624ac.

Gostin, Lawrence, and James G. Hodge Jr. “Potential Discrimination in NYC’s Measles Public Health Emergency Order.” The Hill, April 11, 2019. https://thehill.com/opinion/healthcare/438301-potential-discrimination-in-nycs-measles-public-health-emergency-order.

Lindblom, Eric. “If E-Cigarettes Are a Top Priority, Why Hasn’t the FDA Issued a New Rule?” The Washington Post, March 24, 2019. https://www.washingtonpost.com/opinions/if-e-cigarettes-are-a-top-priority-why-hasnt-the-fda-issued-a-new-rule/2019/03/24/a5efdb58-4cc2-11e9-8cfc-2c5d0999c21e_story.html?utm_term=.30de292acb0f.

Crowley, Jeffrey S. “Trump’s HIV Plan Is Bold. But Can He Back It Up?” Roll Call, March 12, 2019. https://www.rollcall.com/news/opinion/trump-hiv-aids-medicare-aca.

Friedman, Eric A. “How to Achieve Health Equity.” Project Syndicate, March 6, 2019. https://www.project-syndicate.org/commentary/health-equity-sdgs-programs-of-action-by-eric-a-friedman-2019-03.

LaBelle, Regina, and Jeffrey S Crowley. “Building Bridges for Action: Ending the HIV and Opioid Epidemic.” The HIll, February 24, 2019. https://thehill.com/opinion/healthcare/431356-building-bridges-for-action-ending-the-hiv-and-opioid-epidemic.

Gostin, Lawrence O., and Eric A. Friedman. “The Lancet Commission on Global Health Law: How Law Can Advance the Right To Health.” Health Affairs, May 1, 2019. https://www.healthaffairs.org/do/10.1377/hblog20190430.743234/full/.

Gostin, Lawrence O., Scott C. Ratzan, and Barry R. Bloom. “Safe Vaccinations for a Healthy Nation US Vaccine Coverage Through Law, Science, and Communication.” JAMA, April 19, 2019. https://jamanetwork.com/journals/jama/fullarticle/2731738.

Crowley, Jeffrey S., and Sean E. Bland. “Bolstering Latinx Gay and Bisexual Men: To Promote Health and Reduce HIV Transmission,” March 2019. http://oneill.law.georgetown.edu/media/Latinx-Gay-and-Bi-Men.pdf.

Stephens, John. “Tuberculosis in Prison’s: A People’s Introduction to the Law,” January 2019. http://oneill.law.georgetown.edu/media/TB-in-Prisons-Web.pdf.

Stephens, John, Bella Hwang, Amir Shroufi, Tinne Gils, Sarah Jane Steele, Anna Grimsud, Andrew Boulle, et al. “Stock-Outs of Antiretroviral and Tuberculosis Medicines in South Africa: A National Cross-Sectional Survey.” PLOS One, March 12, 2019. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0212405.

Gostin, Lawrence O, Neil R Sircar, and Eric Friedman. “Fighting Novel Diseases amidst Humanitarian Crises.” Hastings Center Report 49, no. 1 (February 21, 2019): 6–9. https://doi.org/https://onlinelibrary.wiley.com/doi/10.1002/hast.970.

Lindblom, Eric N., Andrea C. Johnson, Tiffany Gray, George Luta, and Darren Mays. “How and Why Consumers View ‘Little Cigars’ as Legally-Defined Cigarettes.” Tobacco Regulatory Science 5, no. 2 (March 2019): 124–34. https://www.ingentaconnect.com/content/trsg/trs/2019/00000005/00000002/art00004.

Gostin, Lawrence, Alexandra Phelan, Alex Godwin Coutinho, Mark Eccleston-Turner, Ngozi Erondu, Oyebanji Filani, Tom Inglesby, et al. “Ebola in the Democratic Republic of the Congo: Time to Sound a Global Alert?” The Lancet, February 4, 2019. https://doi.org/https://doi.org/10.1016/S0140-6736(19)30243-0.

Crowley, Jeffrey S, and Sean Bland. “Big Ideas: State and Local ‘End the Epidemic’ Plans Can Drive HIV Progress,” n.d. http://oneill.law.georgetown.edu/media/ONL_Gilead_B1_Zero_P5.pdf.

Crowley, Jeffery S, and Sean Bland. “Big Ideas: Leveraging the Ryan White Program to Make Rapid Start of HIV Therapy Standard Practice,” December 2018. http://oneill.law.georgetown.edu/media/ONL_Gilead_B2_Rapid_P4.pdf.

Crowley, Jeffrey S, and Sean Bland. “Quick Take: HIV Prevention in the United States,” January 2019. http://oneill.law.georgetown.edu/media/HIV-Prevention-Quick-Take-1.pdf.

Crowley, Jeffrey S, and Sean Bland. “Quick Take: The Ryan White HIV/AIDS Program,” January 2019. http://oneill.law.georgetown.edu/media/Ryan-White-Quick-Take.pdf.

Gostin, Lawrence O. “Living, Aging, and Dying in Healthy and Just Societies: Life Lessons From My Father.” The Milbank Quaterly, January 2019. https://www.milbank.org/quarterly/articles/living-aging-and-dying-in-healthy-and-just-societies-life-lessons-from-my-father/.

Gostin, Lawrence O. “The ‘Great’ Generation and a Not-So-Great Health System.” The Milbank Quarterly 95 (December 2017): 698–701. https://www.milbank.org/quarterly/articles/great-generation-not-great-health-system/.

Gostin, Lawrence ). “A Beautiful Life in a Vibrant Yet Vulnerable City.” The Milbank Quaterly Volume 96 (April 2018): 239–43. https://www.milbank.org/quarterly/articles/beautiful-life-vibrant-yet-vulnerable-city/.

Lindblom, Eric N. “Additional Comments Submitted to FDA Re Draft Concept Paper: Illicit Trade in Tobacco Products After Implementation of a Good and Drug Administration Product Standard,” June 22, 2018. https://www.regulations.gov/document?D=FDA-2018-N-0529-0041.

Kavanagh, Matthew, and Vuyiseka Dubula-Majola. “Policy Change and Micro-Politics in Global Health Aid: HIV in South Africa.” Health Policy and Planning, January 9, 2019. https://academic.oup.com/heapol/advance-article/doi/10.1093/heapol/czy103/5281233#.

Lindblom, Eric N. “How FDA Could Use Its Existing Authorities to Make State Legalization of Cannabis More Safe and Effective.” Food & Drug Law Journal, April 2019.

Lindblom, Eric N. “Should FDA Try to Move Smokers to E-Cigarettes and Other Less-Harmful Tobacco Products and, If So, How?” Food & Drug Law Journal 73, no. 2 (May 31, 2018): 276–318. http://oneill.law.georgetown.edu/media/Lindblom-Should-FDA-Move-Smokers-to-E-Cigs-FDLJ.pdf.

Berman, Micah L., Justin Bryon, Natalie Hemmerich, Eric N. Linblom, Allison J. Lazard, Ellen Peters, and Noel T. Brewer. “Communicating Tobacco Product Information to the Public.” Food & Drug Law Journal 72, no. 3 (February 1, 2018): 386–405. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794026/.

Mays, Darren, Andrea Villanti, Raymond S. Niaura, Eric N. Lindblom, and Andrew A. Strasser. “The Effects of Varying Electronic Cigarette Warning Label Design Features on Attention, Recall, and Product Perceptions Among Young Adults.” Journal of Health Communications, December 13, 2017. http://www.tandfonline.com/doi/full/10.1080/10410236.2017.1372050.

Levy, DT, R Borland, and Eric N. Lindblom. “Potential Deaths Averted in USA by Replacing Cigarettes with E-Cigarettes.” Tobacco Control 27, no. 1 (January 2018): 18–25. http://tobaccocontrol.bmj.com/cgi/content/full/tobaccocontrol-2017-053759?ijkey=otCdRShxwj4c1aF&keytype=ref.

Cohn, AM, and Eric N. Lindblom. “Harm Perceptions of Menthol and Nonmenthol Cigarettes Differ by Brand, Race/Ethnicity, and Gender in US Adult Smokers: Results from PATH Wave 1.” Nicotine & Tobacco Research, January 27, 2018. https://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntx277/4827099?searchresult=1.

Moran, MM, and Eric N. Lindblom. “Beyond ‘Natural’: Cigarette Ad Tactics That Mislead about Relative Risk.” Tobacco Regulatory Science 4, no. 5 (September 2018): 3–19. https://www.ingentaconnect.com/contentone/trsg/trs/2018/00000004/00000005/art00001.

Lindblom, Eric N. Comments submitted to FDA re Draft Concept Paper: Illicit Trade in Tobacco Products After Implementation of a Food and Drug Administration Product Standard, No. FDA-2018-N-0529-0001 (May 30, 2018).

Lindblom, Eric N. Comments submitted to FDA re Advance Notice of Proposed Rulemaking: Regulation of Flavors in Tobacco Products, No. FDA-2017-N-6565-0001 (May 30, 2018).

Lindblom, Eric N. Comments submitted to FDA re Advance Notice of Proposed Rulemaking: Tobacco Product Standard for Nicotine Level of Combusted Cigarettes, No. FDA-2017-N-6189 (May 30, 2018).

Lindblom, Eric N. Comments submitted to FDA re Modified Risk Tobacco Product Applications: Applications for IQOS system by Philip Morris Products S.A., No. FDA-2018-N-0529-0001 (June 22, 2018).

Linblom, Eric N., and Darren M. Mays. “Comments Submitted to FDA Re Advance Notice of Proposed Rulemaking: Premium Cigars,” July 16, 2018. https://www.regulations.gov/document?D=FDA-2017-N-6107-7257.

Gravely, S, and Eric N Lindblom. “Discussions between Health Professionals and Smokers about Nicotine Vaping Products: Results from the 2016 ITC Four Country Smoking and Vaping Survey.” Addiction, December 11, 2018. https://www.ncbi.nlm.nih.gov/pubmed/30548374.

Lindblom, Eric N. “How to Regulate Cigarettes? Are We Asking the Right Questions?” presented at the E-Cigarette Summit, Washington, DC, May 8, 2017. http://oneill.law.georgetown.edu/media/Lindblom-E-CigSummitPresentation5-8-17.ppt.

Lindblom, Eric N. “Are There Any Ethical Barriers to Effective Antismoking Measures.” AJPH 107, no. 9 (September 2017): 1364–65. http://ajph.aphapublications.org/doi/abs/10.2105/AJPH.2017.303978.

Lindblom, Eric N. “Effectively Regulating E-Cigarettes and Their Advertising— and the First Amendment.” Food and Drug Law Journal 70, no. 1 (May 2015): 57–94. https://scholarship.law.georgetown.edu/cgi/viewcontent.cgi?article=1094&context=ois_papers.

Yong, H., R. Borland, K.M. Cummings, E.N. Lindblom, and et al. “US Smokers’ Beliefs, Experiences and Perceptions of Different Cigarette Variants before and after the FSPTCA Ban on Misleading Descriptors Such as ‘Light’, ‘Mild’, or ‘low’’.’” Nicotine & Tobacco Research, April 15, 2016. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5055739.

Lindblom, Eric N, ML Berman, and JT Thrasher. “FDA-Required Tobacco Product Inserts & Onserts- and the First Amendment.” Food and Drug Law Journal 72, no. 1 (March 12, 2017). https://www.fdli.org/2017/03/fda-required-tobacco-product-inserts-onserts-first-amendment.

Stay Informed

Signup for our mailing list and stay up to date on the latest happenings at The O’Neill Institute

Or sign up for our RSS Feed

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.